Meiji Yasuda Asset Management CO Ltd. Royalty Pharma PLC Transaction History
Meiji Yasuda Asset Management CO Ltd.
- $2.56 Billion
- Q4 2024
A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 11,952 shares of RPRX stock, worth $403,619. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,952
Previous 11,952
-0.0%
Holding current value
$403,619
Previous $338,000
10.06%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
431Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.34 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$777 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$573 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$477 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...